Breast cancer survivors have a higher risk of developing thyroid cancer, especially within 5 years of their breast cancer diagnosis, according to a national database analysis.
Depressed African American patients with cancer could be more accurately identified if the depression measures used are more culturally sensitive, according to a study.
Sunitinib (Sutent), a drug approved for treatment of several other cancers, may be an effective adjunctive treatment for patients with advanced differentiated thyroid cancer.
Researchers compared tiny variations in the genetic make-up of more than 120,000 women of European ancestry, with and without breast cancer, and identified 15 new genetic variations linked to a higher risk of the disease.
Acute lymphoblastic leukemia (ALL) has been found to have two distinct subtypes, and evidence indicates that roughly 13% of ALL cases may be successfully treated with targeted drugs used in the treatment of lymphomas in adults.